Dan Parry
Director of Finance/CFO presso Hydrexia Pty Ltd.
Profilo
Dan Parry is currently the Chief Financial Officer at Hydrexia Pty Ltd.
Prior to this, he was the Chief Financial & Operating Officer at Oventus Medical Ltd.
from 2017 to 2021.
Before that, he worked as the Chief Financial Officer & Secretary at Implicit Bioscience Ltd.
from 2005 to 2013.
Mr. Parry holds an MBA from Kellogg School of Management.
Posizioni attive di Dan Parry
| Società | Posizione | Inizio |
|---|---|---|
Hydrexia Pty Ltd.
 Hydrexia Pty Ltd. Industrial MachineryProducer Manufacturing Hydrexia Pty Ltd. develops hydrogen storage systems. which engages in the development of hydrogen storage systems. It designs, builds and tests systems that stores hydrogen in solid form, based on a proprietary magnesium alloy. The company was founded in 2006 and is headquartered in Yeerongpilly, Australia. | Director of Finance/CFO | 01/09/2013 |
Precedenti posizioni note di Dan Parry
| Società | Posizione | Fine |
|---|---|---|
| OVES MEDI | Director of Finance/CFO | 04/06/2021 |
Implicit Bioscience Ltd.
 Implicit Bioscience Ltd. BiotechnologyHealth Technology Implicit Bioscience Ltd. operates as a clinical-stage immunotherapy drug development company. It develops drugs that modulate the host immune response to disease. The firm develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents. The company was founded by Garry Llewellyn Redlich, Peter Ronald Andrews and Ian Hector Frazer and is headquartered in Woolloongabba, Australia. | Director of Finance/CFO | 01/01/2013 |
Formazione di Dan Parry
| Kellogg School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Industrial MachineryProducer Manufacturing Hydrexia Pty Ltd. develops hydrogen storage systems. which engages in the development of hydrogen storage systems. It designs, builds and tests systems that stores hydrogen in solid form, based on a proprietary magnesium alloy. The company was founded in 2006 and is headquartered in Yeerongpilly, Australia. | Producer Manufacturing |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Implicit Bioscience Ltd. operates as a clinical-stage immunotherapy drug development company. It develops drugs that modulate the host immune response to disease. The firm develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents. The company was founded by Garry Llewellyn Redlich, Peter Ronald Andrews and Ian Hector Frazer and is headquartered in Woolloongabba, Australia. | Health Technology |
Oventus Medical Ltd.
 Oventus Medical Ltd. Medical SpecialtiesHealth Technology Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. It offers an oral device under the O2Vent brand. The O2Vent unique design directs the air flow through to the back of the throat, alleviating multiple sites of obstruction including the nose, soft palate and tongue The company was founded by Christopher Patrick Hart in 2012 and is headquartered in Indooroopilly, Australia. | Health Technology |
- Borsa valori
- Insiders
- Dan Parry
